Skip to content

Funding Announcements

Filter

Filter & sort

Keyword

Tag

Round

Sort by

Clear

The latest funding rounds from the UK tech ecosystem. Updated 3 August 2026.

Announcements

5,264

Total raised

£158B

disclosed amounts

This month

£232M

raised so far

Seed
£2.0M

The financing round was led by Mastercard and will support accelerated growth across Europe.

"The RegTech market is growing at 45%+ per annum and with 9,000+ Financial Institutions in Europe that must deliver PSD2 open banking, the demand for the Konsentus service is significant and this investment will support an accelerated growth plan across Europe. With plans to launch new related services later in 2019 and international expansion in due course, we will be pursuing a Series A financing round in late 2019"
— Mike Woods, CEO
Series D+
£139M

The Series D financing was backed by returning investors TCV, Accel and Leapfrog Investments to support new product development.

"For more than eight years our core purpose has been and continues to be to help migrants send money to their families, friends and communities. Our customers play a key role in the economies where they work and their remittances are important to their home countries."
— Breon Corcoran, Chief Executive Officer
Series A
£1.0M

Angel CoFund, Beacon Capital, and Richard Hargreaves led the round, which will fund platform development for legal, RPO, and insurance markets.

"autologyx has maintained an excellent track record since we first invested in the team, and they’ve delivered some first class results for customers. Their growth demonstrates a strong market demand for solutions that can help businesses automate everyday processes and increase efficiency. We are pleased to be part of this round supporting autologyx’s continued success."
— Tim Mills, managing partner
Seed
£1.1M

The funding round was led by 24 Haymarket with participation from Innovate UK.

"I was shocked that despite being a treatable condition, pneumonia kills one million children under-five every year – more than HIV, malaria, and TB combined. When I realised these deaths can be avoided through early diagnosis, I became obsessed with finding a way to solve the problem."
— Elina Naydenova, CEO